Chongqing, Chongqing
Disclosures:
3660 - Evaluation of Adjuvant Chemotherapy after Induction Chemotherapy and Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Patients: A Propensity Score-Matched Analysis
Wednesday, October 2, 202410:30 AM – 11:45 AM ET